Search

everythinglearnresearchcommunity

for

Search:↓

Chronic scalp lesions with crusts and pus that heal with strong topical steroids suggest Erosive Pustular Dermatosis, confirmed by biopsy showing specific immune cells.

Topical corticosteroids are the main treatment for Erosive Pustular Dermatosis, but recurrence is common after stopping treatment.

The conclusion is that accurate diagnosis of different types of hair loss requires good teamwork between skin doctors and lab experts.

Early diagnosis and aggressive treatment are key for managing rare scalp disorders that cause permanent hair loss.

Triple horizontal scalp biopsies are 98% accurate in diagnosing hair loss, better than single biopsies.

The document concludes that early diagnosis and treatment are crucial for managing rare hair loss disorders and that more research is needed to improve treatment strategies.

Strong skin creams work well for long-term scalp inflammation in Rapp-Hodgkin Ectodermal Dysplasia.

Some hair loss disorders cause permanent loss due to scarring, and treatments like steroids don't always work well.

A woman with IgG/IgA pemphigus was treated successfully with dapsone and steroids.

The document concludes that early recognition and treatment of primary cicatricial alopecia is crucial to prevent permanent hair loss.

Topical 0.1% tacrolimus significantly improved ear infections in cats.

Permanent hair loss from cicatricial alopecia is treated by reducing inflammation and managing symptoms, but regrowth in scarred areas is unlikely.

The conclusion is that primary scarring alopecia is a complex condition that requires early and accurate diagnosis for effective treatment.

Folliculitis decalvans is a rare scalp condition causing scarring hair loss, treated with long-term antibiotics and other medications, but it often comes back and is hard to manage.

The conclusion is that certain scalp tissue changes are characteristic of lichen planopilaris, with mucinous perifollicular fibroplasia being a new feature for diagnosis.

Loss of sebaceous glands and inflammation may contribute to the development of scarring alopecia.

The document concludes that primary scarring alopecias cause permanent hair loss, have unpredictable outcomes, and lack definitive treatments, requiring personalized care.

Baricitinib helped a woman with severe hair loss regrow almost all her hair without side effects.

Chemotherapy and radiotherapy can cause skin side effects like rashes, hair loss, and nail changes, which are usually managed with conservative treatments.

The document explains various skin conditions and their treatments.

Treatments for permanent hair loss from scarring aim to stop further loss, not regrow hair, and vary by condition, with partial success common.

Proper skin toxicity management in chemotherapy is key to continuing treatment and keeping patient quality of life high.

A 7-year-old dog with a rare autoimmune disease was euthanized due to severe anemia and poor prognosis.

Mexican patients had a lower incidence of skin reactions to drugs and no significant link between these reactions and the TNF2 gene variant.

The document describes skin diseases affecting the outer ear in dogs and cats, their spread to other body parts, and treatment options.

Hidradenitis suppurativa is a chronic skin condition more common in women, linked to genetics and lifestyle factors, and associated with various other health issues.

Frontal Fibrosing Alopecia is a slowly progressing hair loss condition, likely underdiagnosed, with ineffective treatments, needing more research to understand it fully.

Folliculitis decalvans is a rare skin disease causing hair loss and requires personalized treatment.

The skin has a complex immune system that is essential for protection and healing, requiring more research for better wound treatment.

The document concludes that more research is needed to better understand and treat primary cicatricial alopecias, and suggests a possible reclassification based on molecular pathways.